Immuno-Oncology Summit Europe 2019
18th Mar - 22nd Mar
Cambridge Healthtech Institute’s Fourth Annual Immuno-Oncology Summit Europe returns to London for a week of cutting-edge science and discussion. Through six conference tracks, delegates will hear from the research teams at the forefront of the rapidly developing field of cancer biotherapeutics.
As part of the Adoptive T-Cell Therapy track, Dr Jacqueline Barry, Chief Clinical Officer at CGT Catapult will give a talk on Advanced Therapy Delivery from NHS – Clinical Infrastructure Requirements on Friday 22 March, 08:35-09:05.
The ATTC network will also be represented in a panel discussion moderated by Dr Michaela Sharpe, Head of Clinical Development at CGT Catapult and with Dr Fiona Thistlethwaite, iMATCH Director as a panellist. The discussion topic is Safety Management of Cytokine Release and Toxicity and takes place on Friday 22 March, 12:20-12:50.
You can find out more about the event and register here.